Apparently you're correct. Their quality of earnings has been weak for several quarters. Stock buybacks mask much bigger problems. IBM is a proxy for the broader economy and technology in general....although the "strategists" on CNBC will try to spin it otherwise.
It used to be public companies were required, or it was customary to warn the street when their numbers would be missed. Why don't they do that, instead of blindsiding the street with a negative surprise?
Anyone who thinks you wake up on a Monday morning and ebola is now over has no idea of the scope and threat of the virus. This is where you build a new base, not where you sell. A Fibonacci retracement was expected. If you look at the weekly chart, this pre-market activity is normal, and has nothing to do with articles trying to play down the global threat.
I have no position, but will ride it back up after buying in the $14's or less.
As I've been telling everyone the past couple of weeks, NewLink is not just an Ebola stock. Shorts made that mistake. This confirmation of their cancer portfolio with this collaboration is huge, as the street confirms with the gap up in pre-market. And if NewLink does get the ebola vaccine, then all bets are off.....we could rise over $75 before the end of the year.....seriously.
It's a journey....along the way, they let people off the bus who want to get off, or can't afford to travel further. Once that happens, then they can proceed to the next destination. That's what's happening now.
No worries, unless you're on heavy margin. The stock just broke out on heavy volume yesterday, and the weekly chart is still in great shape, so this is an opportunity to add to your position. I would advise buying in a cash account, rather than margin, but keep in mind NewLink probably has the vaccine that will be a first mover to head off this virus.
It looks like the market makers keep throwing up a 40,000 block on the ask at $30, in my opinion to collect shares lower before a huge move up over $30. Once it trades over $30, there's not much there in the way of resistance, and the MM's know this could head to $40 in a hurry. With that resistance, I look for a brief pullback through the midday here.
For those long this stock, it's almost obvious to the street that NewLInk is getting a very warm reception over at the FDA right now. This will probably not be your normal everyday trial cycle for drugs, i.e. Phase I can quickly move on to II and III, given the efficacy of this vaccine.
Technical traders.....take a look at the weekly chart for NLNK......I anticipate a huge move up, or even a possible stock halt within the next week or two.
You're obviously not in the medical field.....I am.....Everyone at our facility and their families are invested in NewLink. I highly suggest you rethink your position, and soon.
The cancer portfolio is very viable, but I think the ebola vaccine is being rushed through the process given the immediate need. NLNK's vaccine has had very promising results, and I think the stock will spike over $50 if it becomes the vaccine of choice.
Read their article on their website regarding their submission of info the the FDA, and the progress thus far.
I've done my homework, I'm in the medical field, and I've concluded that the street is correct in their assumption that NewLink will be the savior with their vaccine, currently being evaluated. If the trial is a success as anticipated, NLNK could be acquired very quickly by a big pharma player.
Fun....keep in mind that last night in AH, UVXY dropped big while XIV went up proportionately......and then the market did the opposite in the am (today), so although the futures players control the markets more than people would like to think, they're not always correct in their assumptions.
The FDA questions the NDA filing with a refusal, and they have the go ahead to start clinical studies for their cannabis product. I'm more concerned about the former myself.
I get the Netflix trade in AH causing volatility nfp, but XIV is generally a very liquid inverse VIX play. I guess maybe the market is assuming NFLX will cause an am selloff tomorrow, but the market has to bounce at some point. But over $2 down for XIV in AH is a lot, esp. when you consider the low of the day for XIV at $24.67 is only 1.5 points below where it's trading now in AH at $26.10, and that low was when the broader market was down about 450 points!
Big pharma is salivating as I type. If the vaccine trial has any degree of success, NLNK would probably be acquired for at least $50......or more.